An important part of understanding the impact of COVID-19 on business value is understanding the virus itself. Exhaustive research and analysis has gone into the BVR Briefing, “The Real Story of COVID-19 for Valuation and Litigation Experts,” which author Mark Dietrich (Mark O. Dietrich CPA, PC), a nationally known healthcare finance and valuation expert, has just updated with current data. The briefing includes a focus on healthcare entities, but Dietrich’s insights into how the virus originated, how it spreads, protection methods, testing, and so on are important to all valuation and financial experts. His update includes a look at the dramatic changes in the evolution of the virus since the briefing was first issued, disputes over new research, conflicting opinions over proposed treatments, testing issues, and the current status of vaccine development. “My goal here is to inform readers, not direct them to one conclusion or another,” says Dietrich, whose research goes directly to the source data in various scientific journals and fact-based websites. “I offer my view of things but encourage readers to conclude for themselves and to fact-check as they see fit.” The updated BVR Briefing is available if you click here.
Note: If you have already purchased the briefing, you will receive the update as a separate document from BVR. If you are a first-time purchaser, the update is included in the briefing you will receive.
Please let us know
if you have any comments about this article or enhancements you would like to see.